Project briefs · Health & Life Sciences
Amgen · Summer 2027
U.S. Value & Access Intern: a project built for this posting
The intern owns a project on a live business priority for Amgen's U.S. Value & Access organization, which shapes how medicines are priced, covered and reimbursed in the US system. They analyze the problem with cross-functional experts, support planning and forecasting for a business unit's products, and present recommendations to leadership at the end of the summer.
- Company
- Amgen
- Posting title
- Undergrad intern - U.S. Value & Access (Summer 2027)
- Location
- Remote
- Season
- Summer 2027
- Pay (as posted)
- $28.87 per hour
- Majors named
- Economics, Business Administration, Biotechnology Management, Biomedical Engineering, Chemistry, Biology, Statistics, Accounting, Finance, Life Science & Business dual degree
Checked open on the employer's careers site on 2026-10-16. Read the full posting ↗
What this role is really testing
The project
Biosimilar Market Entry: A Value & Access Mini-Brief
A one-page strategic brief and supporting Excel model analyzing a real biosimilar's U.S. market entry, covering payer coverage dynamics, list-to-net pricing assumptions, and a prioritized access recommendation. This mirrors exactly what a Value & Access intern would produce, turning public data into a structured, decision-ready output for commercial leadership.
- Pick one recently launched U.S. biosimilar (e.g., a biosimilar adalimumab). Use publicly available sources, the FDA biosimilar product list, CMS drug spending dashboards, and one or two press releases or 10-K filings, to pull three data points: estimated list price, any disclosed net price range or rebate estimate, and at least two major payer formulary tier placements. Record these in a clean Excel tab labeled 'Market Snapshot' with labeled rows, source citations in an adjacent column, and a simple bar or waterfall chart showing list-to-estimated-net price erosion.
- Add a second Excel tab labeled 'Access Forecast' with a basic patient funnel model: start with an assumed diagnosed eligible population (pull a published prevalence figure and cite it), apply sequential discount rates for payer coverage rate, formulary access rate, and projected market share in year one versus year two. Use dropdown-driven assumption cells highlighted in yellow so a reviewer can stress-test your inputs instantly. Keep formulas visible and unlocked, this signals analytic transparency, a core Value & Access norm.
- Write a one-page Word or Google Doc brief titled 'Access Recommendation: [Biosimilar Name]' structured in four labeled sections, Situation (market context in three sentences), Complication (the specific access barrier your data surfaces, e.g., unfavorable formulary tier or steep rebate requirement), Recommendation (one prioritized action such as a targeted payer contracting strategy or patient assistance program design), and Key Risks (two bullets). Keep the entire document to one page, use no jargon without a parenthetical definition, and paste your waterfall chart from Excel directly into the brief so it stands alone as a shareable artifact.
Free account. Provieo walks you through it and turns it into a page with a link you can put on your application. This posting comes with you.
Questions
Do I need to know how to code?
No. For roles like this one, Provieo builds the project as a live case-study page: slides, tables and findings you fill in. You bring the thinking.
Where did this project come from?
Provieo read the Amgen posting and generated it on 2026-10-16. If you paste the same posting yourself you may get a different project, so two applicants don't show up with the same one.
Is Provieo connected to Amgen?
No. This is an independent project idea based on a public posting. It does not guarantee an interview.